Recent Research and Innovations in Oncology


Continuous malignant tumor drug discovery and development is vital to seek out an entire cure for cancer. Because of the drug resistance developed by tumor cells for existing treatments, this is often changing into a compulsory approach to fight the illness.



• Scientific investigations on inhibitors of stop CHK1 will be another milestone for antineoplastic drug discovery approach.



• Cancer cells are specifically dependent on molecular chaperones and related proteins that regulate homeostasis. These are promising targets for new anticancer therapies.



• Deregulated necrobiosis is hallmark of cancer and Bcl-2 family of proteins are crucial to mediating the pathway of this method. Inhibiting their method may be a big approach for developing new malignant tumor medication. Several plant sources are noted to be valuable sources of novel anti-cancer properties.


    Related Conference of Recent Research and Innovations in Oncology

    March 18-19, 2024

    5th Global Summit on Oncology and Hematology

    Zurich, Switzerland
    June 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Barcelona, Spain
    July 11-12, 2024

    24th World Congress on Cancer and Diagnostics

    Vancouver, Canada
    July 18-19, 2024

    14th World Congress on Breast Cancer

    Paris, France
    September 19-20, 2024

    25th World Congress on Cancer Summit

    Paris, France

    Recent Research and Innovations in Oncology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in